The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Novartis; Roche
 
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; Cellectis; Daiichi Sankyo; ImmunoGen; Incyte; Janssen; Jazz Pharmaceuticals; Menarini; Novartis; Otsuka; Pfizer; SERVIER; Shire; Sunesis Pharmaceuticals
Research Funding - Amgen (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst)

Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse: Results from the phase III QUAZAR AML-001 maintenance trial.
 
Hartmut Dohner
Honoraria - Abbvie; Celgene; Jazz Pharmaceuticals; Novartis
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Celgene; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Servier
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Hervé Dombret
No Relationships to Disclose
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Orsenix; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Orsenix; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Merck; Seagen; Selvita; Sunesis Pharmaceuticals; Xencor
 
Hamid Sayar
No Relationships to Disclose
 
Kimmo Porkka
No Relationships to Disclose
 
Irwindeep Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; Takeda
 
Francesco Passamonti
No Relationships to Disclose
 
Fabrizio Pane
Consulting or Advisory Role - Abbvie; Amgen; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis
Speakers' Bureau - Abbvie; Amgen; Jazz Pharmaceuticals; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Daiichi Sankyo; Janssen; Jazz Pharmaceuticals; Novartis
 
Tadeusz Robak
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Jose F. Falantes
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
 
Andre C. Schuh
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Agios; Amgen; Bristol-Myers Squibb; Jazz Pharmaceuticals
 
Gert J. Ossenkoppele
Consulting or Advisory Role - Agen; Agios; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Jazz Pharmaceuticals; Johnson & Johnson; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Johnson & Johnson (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Ignazia La Torre
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Barry Skikne
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Keshava Kumar
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Qian Dong
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
C. L. Beach
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Amphivena; argenx; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; Bayer; Bayer; Celgene; Celltrion; Daiichi Sankyo; Eisai; Genentech/Roche; Genoptix; Janssen; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Novartis; Orsenix; Otsuka; Pfizer; Roche; Sandoz; Takeda; Trovagene
Research Funding - Abbvie (Inst); Agios (Inst); amphivena (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); Cellectis (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Agios; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals